» Articles » PMID: 30123111

Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3 Mouse Model of Autism

Overview
Specialty Cell Biology
Date 2018 Aug 21
PMID 30123111
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding neuronal mechanisms underlying aggression in patients with autism spectrum disorder (ASD) could lead to better treatments and prognosis. The Neuroligin-3 (NL3) mouse model of ASD has a heightened aggressive phenotype, however the biological mechanisms underlying this behavior are unknown. It is well established that NL3 mice have imbalanced excitatory and inhibitory synaptic activity in the hippocampus and somatosensory cortex. The amygdala plays a role in modulating aggressive behavior, however potential changes in synaptic activity in this region have not previously been assessed in this model. We investigated whether aggressive behavior is robustly present in mice expressing the R451C mutation, following back-crossing onto a congenic background strain. Endocannabinoids influence social interaction and aggressive behavior, therefore we also studied the effects of cannabinoid receptor 1 (CB1) agonist on NL3 mice. We report that NL3 mice have increased amplitude of miniature excitatory postsynaptic currents (EPSCs) with a concomitant decrease in the amplitude of inhibitory postsynaptic currents (IPSCs) in the basolateral amygdala. Importantly, we demonstrated that NL3 mice bred on a C57Bl/6 background strain exhibit an aggressive phenotype. Following non-sedating doses (0.3 and 1.0 mg/kg) of the CB1 receptor agonist WIN55,212-2 (WIN), we observed a significant reduction in aggressive behavior in NL3 mice. These findings demonstrate altered synaptic activity in the basolateral amygdala and suggest that the NL3 mouse model is a useful preclinical tool to understand the role of CB1 receptor function in aggressive behavior.

Citing Articles

Autistic Traits and Aggressive Behavior in Chinese College Students: A Serial Mediation Model and the Gender Difference.

Tan C, Song H, Ma S, Liu X, Zhao Y Psychol Res Behav Manag. 2024; 17:1385-1397.

PMID: 38529081 PMC: 10962467. DOI: 10.2147/PRBM.S451028.


Frontostriatal circuit dysfunction leads to cognitive inflexibility in neuroligin-3 R451C knockin mice.

Lin S, Fan C, Wang H, Li X, Zeng J, Lan P Mol Psychiatry. 2024; 29(8):2308-2320.

PMID: 38459194 DOI: 10.1038/s41380-024-02505-9.


Faster Gastrointestinal Transit, Reduced Small Intestinal Smooth Muscle Tone and Dysmotility in the Mouse Model of Autism.

Hosie S, Abo-Shaban T, Mou K, Balasuriya G, Mohsenipour M, Alamoudi M Int J Mol Sci. 2024; 25(2).

PMID: 38255906 PMC: 10815490. DOI: 10.3390/ijms25020832.


The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.

Hill M, Haney M, Hillard C, Karhson D, Vecchiarelli H Psychol Med. 2023; 53(15):7006-7024.

PMID: 37671673 PMC: 10719691. DOI: 10.1017/S0033291723002465.


Impaired cecal motility and secretion alongside expansion of gut-associated lymphoid tissue in the Nlgn3 mouse model of autism.

Lee C, Balasuriya G, Herath M, Franks A, Hill-Yardin E Sci Rep. 2023; 13(1):12687.

PMID: 37542090 PMC: 10403596. DOI: 10.1038/s41598-023-39555-y.


References
1.
Rodriguez-Arias M, Navarrete F, Daza-Losada M, Navarro D, Aguilar M, Berbel P . CB1 cannabinoid receptor-mediated aggressive behavior. Neuropharmacology. 2013; 75:172-80. DOI: 10.1016/j.neuropharm.2013.07.013. View

2.
Betancur C . Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2010; 1380:42-77. DOI: 10.1016/j.brainres.2010.11.078. View

3.
Lein E, Hawrylycz M, Ao N, Ayres M, Bensinger A, Bernard A . Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2006; 445(7124):168-76. DOI: 10.1038/nature05453. View

4.
Adler B, Wink L, Early M, Shaffer R, Minshawi N, McDougle C . Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study. Autism. 2014; 19(1):102-6. DOI: 10.1177/1362361314524641. View

5.
Chubykin A, Liu X, Comoletti D, Tsigelny I, Taylor P, Sudhof T . Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J Biol Chem. 2005; 280(23):22365-74. DOI: 10.1074/jbc.M410723200. View